
Upon completion of five-year project, the location will serve as Asian hub for dose manufacturing

Upon completion of five-year project, the location will serve as Asian hub for dose manufacturing

Dedicate new high-speed vial filling line for production of Moderna's Covid-19 vaccine

Agreement will now include fill-finish services at San Diego facility

With construction of third production line finished, biotech company says it can manufacture two billion doses annually

Acquisition further develops KD Pharma’s CDMO capabilities

The big pharma will help fill and finish up to 60 million doses of Novavax' coronavirus candidate

Expansion in response to growing industry demand for products to transport temperature-sensitive cell and gene therapies

Location will be purchased by WuXi Biologics, according to report

Puts packaging business on pace for 2 billion by end of year

The 130,000-square-foot site will be the CDMO's third location

Marks the latest big pharma partnership for CureVac around its Covid vaccine candidate, CVnCoV

In extension of J&J agreement, deal provides manufacturing facilities for Covid-19 vaccine production

Rivals will team up in order to accelerate supply

Joins network of manufacturers contributing efforts to increase supply

Joins UK consortium to help efficiently manufacture oral solid dosage medication

Company says it will be able to produce an estimated 12 million doses per month

The importance of thinking strategically about the infrastructure and foresight needed to scale up CGTs—not as treatments of last resort, but first choice

Lab development project features 9,000-square-foot expansion

Results address concerns surrounding bulk passive pharma packaging

$180M collaboration aims to introduce multiple vaccine candidates in 2022

Two-dose COVAXIN currently under EUA in India

Rating for packaging supplier highlights its commitment to sustainable practices and corporate social responsibility

In Phase III at the moment, mRNA dose will be produced at Bayer's Wuppertal, Germany facility

Production expected to begin in the second quarter

Boston-area location will be fully operational in Q4